USD10
RNA Shares
About Atrium TherapeuticsAtrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
USD10
RNA Shares
About Atrium TherapeuticsAtrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$233.49M
OPEN PRICE
$13.40
LOW (1Y)
$11.40
HIGH (1Y)
$16.77
LOW (24H)
$13.20
HIGH (24H)
$13.72
VOLUME (24H)
$196.86K
30.92%
Price history
Time | Price | Change |
|---|---|---|
Today | $13.40 | |
1 Day | $13.65 | 0.00% |
1 Week | $13.30 | |
1 Month | $12.38 | |
1 Year | $28.80 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.